Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/Departments
Researchers
Research output
Activities
Prizes
The therapeutic impact of new migraine discoveries
Laszlo Vécsei, Melinda Lukács, Janos Tajti, Ferenc Fülöp, Jozsef Toldi, Lars Edvinsson
16
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The therapeutic impact of new migraine discoveries'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Migraine
100%
Therapeutic Impact
100%
Therapeutic Strategies
40%
Clinical Practice
20%
Substance P
20%
PubMed
20%
Clinical Trials
20%
Tolerability
20%
Antimigraine Drugs
20%
Trigeminovascular System
20%
Triptans
20%
Systematic Literature Review
20%
Migraine Pathophysiology
20%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
20%
Migraine Patients
20%
Migraine Attack
20%
Prophylactic Treatment
20%
Chronic Migraine
20%
Acute Migraine Treatment
20%
Neurological Diseases
20%
Preventive Treatment
20%
Migraine Prevention
20%
Therapeutic Challenges
20%
Monoclonal Antibody
20%
Therapeutic Approaches
20%
Transient Receptor Potential Vanilloid 1 (TRPV1)
20%
New Therapeutics
20%
Ongoing Clinical Trials
20%
Current Therapeutics
20%
Socioeconomic Costs
20%
Episodic Migraine
20%
Glutamate Receptor Antagonists
20%
Orexin
20%
Kynurenic Acid
20%
Pathomechanism
20%
Migraine Research
20%
5-HT1F Receptor Agonist
20%
CGRP Receptor
20%
Patient-specific Treatment
20%
Promising Therapeutics
20%
Pharmacology, Toxicology and Pharmaceutical Science
Migraine
100%
Clinical Trial
16%
Preclinical Study
16%
Pathophysiology
8%
Tolerability
8%
Triptan Derivative
8%
Calcitonin Gene Related Peptide
8%
Calcitonin Gene Related Peptide Receptor
8%
Transformed Migraine
8%
Receptor Agonist
8%
Clinical Study
8%
Monoclonal Antibody
8%
Glutamate Receptor Antagonist
8%
Hypophysis Adenylate Cyclase Activating Polypeptide
8%
Substance P
8%
Episodic Migraine
8%
Orexin
8%
Kynurenic Acid
8%
Side Effect
8%
Neuroscience
Migraine
100%
Substance P
8%
Receptor Agonists
8%
Glutamate Receptor
8%
Calcitonin Gene-Related Peptide Receptor
8%
Hypophysis Adenylate Cyclase Activating Polypeptide
8%
Trigeminovascular System
8%
Antimigraine Drugs
8%
Receptor Antagonist
8%
Orexin
8%
Monoclonal Antibody
8%
Kynurenic Acid
8%
5-HT1F Receptor
8%
TRPV1
8%
Side Effect
8%
Calcitonin Gene Related Peptide
8%